Biobanks Market Overview:
Biobank is basically a type of biorepository which stores the biological samples (mainly human samples) used for research purposes or even for treatment. Biobanks play a vital role in the field of biomedical research. The wide range of biospecimens includes samples of blood, saliva, plasma, and purified DNA which can be described as libraries of the human organism. Before biobanks came into the market doctors use to collect the samples only for their own research purpose but the biobanks gave researchers access to data representing a large number of people.
Biobanks Market Forecast Report (2019- 2024):
Global Biobanks Market is expected to increase at a CAGR of 7.68% in the forecast period of 2019-2024 and reach a value of USD 324.9 million by 2024 from USD 224.5 million in 2019.
Biobanks Market Growth:
Dependence of researchers from all scientific realms on biobanks increased tremendously for providing samples. For the industrial development of diagnostics and therapeutics as well as for medical research biological material and related data have become an important resource. There is an inclination in the market for Biopreservation systems due to an increase in demand for tissue banking, stem cell banking and umbilical cord banking.
The key driver for the market is poor productivity rate of the pharmaceutical industry with respect to the new drug approvals. The vision of personalized medicine is also endorsed for the growth of this market. These storage solutions can reduce the testing time and costs for manufacturers, as a testing laboratory can take up to 3 days for testing but if the hospital themselves have the storage bank the time can reduce to 3 hours. The major drawbacks involve storage and handling problem, regulatory issues and cost competitive procedures.
The human tissues section is expected to account for the highest market share of approximately 65% during the forecast period. Preference for human tissue specimens is increasing over animal tissue samples due to unavailability of appropriate animal models for some specific neurological and psychiatric disorders.
Biobanks Market is segmentation:
Geographical Analysis
The US has the largest market share followed by the European market while growth in the Asia Pacific region is increasing rapidly and driven by the rise in population and increasing healthcare spending from government bodies. Asia Pacific region is predicted to show tough competition with the developed regions.
Biobanks Market Key Players:
The key players in the biopreservation market are
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Equipment’s
5.1.1.1 Temperature control systems
5.1.1.2 Incubators
5.1.1.3 Centrifuges
5.1.1.4 Alarm and Monitoring Systems
5.1.1.5 Accessories
5.1.1.6 Other Equipment's
5.1.2 Consumables
5.2 By Sample Type
5.2.1 Human Tissues
5.2.2 Stem Cells
5.2.3 DNA or RNA
5.2.4 Bio-fluids
5.2.5 Other Sample Type
5.3 By Application
5.3.1 Therapeutic Applications
5.3.2 Research Applications
5.3.3 Clinical Trials
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Argentina
6.4.5 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Tecan group
8.3 Taylor- Wharton
8.4 Panasonic biomedical
8.5 Teva pharmaceuticals
8.6 Biolife solutions
8.7 Custom biogenic systems
8.8 Princeton cryotech
8.9 Fluidx
8.10 Tissue solutions
8.11 Wildcat laboratory solutions
8.12 Micronik
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
